bibliogrbibliography aphyaphy -...

Effect of Pranayama on chronic bronchial asthma

BibliogrBibliogrBibliogrBibliographyaphyaphyaphy

Bibliography

Effect of Pranayama on Chronic bronchial Asthma 151

1. Hippocrates, Greek Physician, 460-375 BC.

2. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med

2001;344(5):350–62.

3. Global Initiative for Asthma Management and Prevention (GINA).

Revised edn.2006. Definition and Overview, pg. no.7.

4. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease

persistence and progression. Annu Rev Immunol 2004; 22:789- 815.

5. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM.

Asthma, from bronchoconstriction to airways inflammation and

remodeling. Am J Respir Crit Care Med 2000; 161(5):1720-45.93.

6. James A. Airway remodeling in asthma. Curr Opin Pulm Med

2005; 11(1):1-6.

7. Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj

M, et al. Airway remodeling in asthma. Chest 2003; 123

(3 Suppl):417S-22S.

8. Paul M O’Byrne. Daily inhaled corticosteroid treatment should be

prescribed for mild to persistent asthma. Am J Respir Crit Care Med

2005; 172: 410-12.

9. Krishnan, Sripriya. “Yoga – A Remedy To Respiratory Illness”.

Proceedings of the Third International Conference on Environment

and Health, 2003; 253-251.

10. Ming-Chun Wen, MD, Chun-Hua Wei, MD, Zhao-Qiu Hu, MD,

Efficacy and tolerability of anti asthma herbal medicine intervention

in adult patients with moderate-severe allergic asthma. Allergy &

Immunology. 2005; 9 (3): 517-524.

11. S Allen, JR Britton, JA Leonardi-Bee. Association between

Bibliography


antioxidant vitamins and asthma outcome measures: systematic

review and meta-analysis. Thorax 2009; 64:610-619.

12. Kaptchuk R Jr. The web that has no weaver: Understanding Chinese

medicine. 2nd edn. 2000.

13. Lehrer, Paul M, Vaschillo, Evgeny; Vaschillo, Bronya et al.

Biofeedback Treatment for Asthma. Chest, August 2004; 126(2):

352-361.

14. Leela Shekar. Swallowing a live fish may get rid of asthma. India

Environmental Portal, 1993.

15. Naturopathic medicine, © Michael Alan Morton Ph.D, Mary

Morton; excerpted from “Five steps to selecting the best alternative

Medicine, New world Library; 1997.

16. K.M. Citron, S. Black, J.A. Crocket, D. Davies, P.J.D. Heaf et al.

Hypnosis for Asthma – a controlled trial. Brit Med J. 1968; 4: 71-76.

17. Vedanthan M.D., Lakshmyya N, Kesavalu, Krishna C, Murthy et al.

Clinical study of Yoga techniques in University students with

Asthma: A controlled study. Allergy Asthma Proc. 1998; 19(1):3-9.

18. Murthy KRJ; Sahay BK; Sitaramaraju P; Sunita M; Yogi R. Effect of

pranayama (rechaka, puraka and kumbaka) on bronchial asthma - an

open study. Lung India 1984; 2(2): 187-91.

19. Nagendra HR and Nagarathna R, An integrated approach of yoga

therapy for bronchial asthma: a 3-54-month prospective study. J

Asthma 1986; 23(3):123-37.

20. Nagarathna R, Nagendra HR. Yoga for Bronchial asthma: A

controlled study. British Medical Journal (Clin Res Ed) 1985;

291:1077-1079.

21. Cooper S, Oborne J, Newton S, Harrison V, Thompson Coon J et al.

Bibliography


Effect of two breathing exercises (Buteyko and pranayama) in

asthma: A randomized controlled trial. Thorax, 2003 Aug; 58(8):674-

9.

22. Holloway EA. Breathing exercises for asthma. Cochrane Database of

Systamatic Reviews 2004, issue1. Art. no: CD001277, DOI:

10.1002/14651858.

23. Thomas M, McKinley RK, Freeman, C Foy, P Prodge et al.

Breathing retraining for dysfunctional breathing in asthma: A

randomized controlled trial. Thorax 2003; 58:110-5.

24. Holloway E, West R. Integrated breathing and relaxation training,

(the Papworth method) for adults with asthma in primary care: A

randomized trial. Thorax 2007; 62:1033-4.

25. Slader CA, Reddel HK, Spencer LM, Belousova EG, Armour CL et

al. Double blind randomized controlled trial of two different

breathing techniques in the management of asthma. Thorax 2006;

61:643-5.

26. Marc J Sicklick, M D, Asthma and Breath management. 2006.

http://yourtotalhealth.ivillage.com/allergy-asthma.

27. GINA-Global Initiative for Asthma Management and Prevention,

revised edn.2006. Prevalence of Asthma, pg no: 18.

28. Fishman’s Pulmonary Diseases and Disorders, 2008; volume I,

4th edition, pg. no: 790-791.

29. Sidney S Burman. The Global burden of asthma. Chest 2006,130

no.1 suppl 4s-12s.

30. ER McFadden Jr, Harrison’s Principles of Internal Medicine. Vol II,

16th edn; 2005, pg no: 1508.


Bibliography


Revised edn.2006. Definition and Overview, pg. no.17.

32. National Heart Lung and Blood Institute – National Asthma

Education and Preventive program. Expert panel report 3: Guidelines

for the diagnosis and management of Asthma: 28 (8) 2007, pg no: 34

– 43.

33. Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on

aspirin sensitivity and asthma. J Allergy Clin Immunol 2006;

118(4):773–86.

34. Holgate ST, Polosa R. The mechanisms, diagnosis, and management

of severe asthma in adults. Lancet 2006; 368(9537):780–93.

35. Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J et al. CD4+

invariant T-cell-receptor+ natural killer T cells in bronchial asthma.

N Engl J Med 2006; 354(11):1117–29.

36. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the

pathogenesis of asthma. J Allergy Clin Immunol 2003; 111(3):450–

63.

37. Barnes PJ. Cytokine modulators as novel therajainpies for asthma.

Annu Rev Pharmacol Toxicol 2002; 42:81–98.

38. Zimmermann N, Hershey GK, Foster PS, Rothenberg ME.

Chemokines in asthma: cooperative interaction between chemokines

and IL-13. J Allergy Clin Immunol 2003; 111(2):227–42.

39. Boyce JA. Mast cells: Beyond IgE. J Allergy Clin Immunol 2003;

111(1):24–32.

40. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM,

Williams CM et al. Mast cells as "tunable" effector and

immunoregulatory cells: recent advances. Annu Rev Immunol 2005;

23:749–86.

Bibliography


41. Robinson DS. The role of the mast cell in asthma: induction of

airway hyperresponsiveness by interaction with smooth muscle? J

Allergy Clin Immunol 2004; 114(1):58–65.

42. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ et

al. Mast-cell infiltration of airway smooth muscle in asthma. N Engl

J Med 2002; 346(22):1699–1705.

43. Chu HW, Martin RJ. Are eosinophils still important in asthma? Clin

Exp Allergy 2001; 31(4):525–28.

44. Sampson AP. The role of eosinophils and neutrophils in

inflammation. Clin Exp Allergy 2000; 30 Suppl 1:22–7.

45. Williams TJ. The eosinophil enigma. J Clin Invest 2004; 113(4):

507-9.

46. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls

CM et al. Effects of an interleukin-5 blocking monoclonal antibody

on eosinophils, airway hyper-responsiveness, and the late asthmatic

response. Lancet 2000; 356(9248):2144–8.

47. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic

inflammation in sputum from subjects with asthma exacerbation. J


48. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF et al.

Neutrophilic inflammation in severe persistent asthma. Am J Respir

Crit Care Med 1999; 160:1532–9.

49. Wenzel SE. Asthma: defining of the persistent adult phenotypes.

Lancet 2006; 368(9537):804–13.

50. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD et al.

Bronchoscopic evaluation of severe asthma. Persistent inflammation

associated with high dose glucocorticoids. Am J Respir Crit Care

Bibliography


Med 1997; 156(3):737–43.

51. Kuipers H, Lambrecht BN. The interplay of dendritic cells, Th2 cells

and regulatory T cells in asthma. Curr Opin Immunol 2004;

16(6):702–8.

52. Peters-Golden M. The alveolar macrophage: the forgotten cell in

asthma. Am J Respir Cell Mol Biol 2004; 31(1):3–7.

53. Polito AJ, Proud D. Epithelia cells as regulators of airway

inflammation. J Allergy Clin Immunol 1998; 102(5):714–8.

54. Busse WW. The role of leukotrienes in asthma and allergic rhinitis.

Clin Exp Allergy 1996; 26(8):868–79.

55. Leff AR. Regulation of leukotrienes in the management of asthma:

biology and clinical therapy. Annu Rev Med 2001; 52:1–14.

56. Gelfand EW, Dakhama A. CD8+ T lymphocytes and leukotriene B4:

novel interactions in the persistence and progression of asthma. J


57. Deykin A, Massaro AF, Drazen JM, Israel E. Exhaled nitric oxide as

a diagnostic test for asthma: online versus offline techniques and

effect of flow rate. Am J Respir Crit Care Med 2002; 165(12):1597–

1601.

58. Strunk RC, Szefler SJ, Phillips BR, Zeiger RS, Chinchilli VM et al;

Childhood Asthma Research and Education Network of the National

Heart, Lung, and Blood Institute. Relationship of exhaled nitric oxide

ato clinical and inflammatory markers of persistent asthma in

children. J Allergy Clin Immunol 2003; 112(5):883–92.

59. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D et al.

Asthma exacerbations and sputum eosinophil counts: a randomised

controlled trial. Lancet 2002; 360(9347):1715–21.

Bibliography


60. Sporik R, Ingram JM, Price W, Sussman JH, Honsinger RW et al.

Association of asthma with serum IgE and skin test reactivity to

allergens among children living at high altitude. Am J Respir Crit

Care Med 1995; 151(5):1388–92.

61. Ólafsdottir I. S., Gislason T., Thjodleifsson B., Olafsson Í., Gislason

D et al. (2005): C reactive protein levels are increased in non-allergic

but not in allergic asthma: a multicentre epidemiological study.

Thorax, 2005, 60: 451–454.

62. Qian FH, Zhang Q, Zhou LF, Liu H, Huang M. High-sensitive C-

reactive protein: a predictive marker in severe asthma.

Respirology, 2008 Sep; 13(5): 664-9.

63. Takemura M, Matsumoto H, Niimi A, Ueda T, matsuoka H. High

sensitive C-reactive protein in asthma. Eur Resp J, 2006 May;

27(5):908-12.

64. Bateman ED, Boushey H, Busse WW, Clark JH, Romain A et al. Can

guideline-defined asthma control be achieved? Am J Respir Crit Care

med 2004; 170:836-44.


Revised edn.2006. Asthma treatments, pg. no.28.

66. Seaton Anthony Crofton and Douglas; Respiratory Diseases. 5th

edn.Vol.2, Pg 976-98.

67. Kraan J, Koëter GH, Van Der Mark TW, Sluiter HJ, De Vries K.

Changes in bronchial hyperreactivity induced by 4 weeks of

treatment with anti – asthmatic drugs in patients with allergic asthma:

a comparison between Budesonide and terbutaline. J Allergy Clin

Immunol 1985; 76:628.

68. Vathenen AS, Knox AJ, Higgins BG, Britton JR, Tattersfield AE.

Bibliography


Rebound increase in bronchial responsiveness after treatment with

inhaled terbutaline. Lancet 1988; i: 554.

69. Kerrebijn KF, Essen – zandvliet EEM, Neijens HJ. Effect of long –

term treatment with inhaled corticosteroids and beta – agonists on the

bronchial responsiveness in children with asthma. J Allergy Clin

Immunol 1987; 79:653.

70. Van Schayck CP, Graafsma SJ, Visch MB, Dompeling E, Van Weel

C et al. Increased bronchial hyperresponsiveness after inhaling

salbutamol during one year is not caused by subsensitisation to

salbutalmol. J Allergy Clin Immunol 1990; 86: 93.

71. Sears MR, Taylor DR, and Print CG et al. Regular inhaled beta-

agonist treatment in bronchial Asthma. Lancet 1990; 336:1391.

72. Van Schayck CP, Dompeling E, Van Herwaarden CLA.

Bronchodilator treatment in moderate Asthma or chronic bronchitis:

continuous or demand. A randomized controlled trial. Br Med J 1991;

303:1426.

73. National Heart Lung and Blood Institute – National Institutes of

Health. International Consensus report on Diagnosis and

Management of asthma. Eur Respir J 1992; 5:601.

74. British Thoracic Society. The British guidelines on asthma

management; 1995 review and position statement. Thorax 1997;

52:S1.

75. Pearce N, Grainger M, Atkinson M, Crane J, Burgess et al. Case

controlled study of prescribed Fenoterol and death from asthma in

New Zealand, 1977-1980. Thorax 1990; 45:170

76. Tattersfield AE, Britton JR. β2- adrenoreceptor agonists. In: Barnes

PJ, Rodger IW, Thomson NC, eds. Asthma: Basic Mechanisms and

Bibliography


Clinical Management.London, Academic Press; 1992:527.

77. National Asthma Education Program. Asthma management

handbook. Melbourne: National Asthma Campaign, 1993.

78. Jenne JW. Physiology and Pharmacodynamics of Theophylline. In:

Jenne JW, Murphy S, eds. Drug Therapy for Asthma: Research and

Clinical Practice. New York: Marcel Dekker, 1987:297.

79. Jenne JW, Wyse E, Rood BS, McDonald FM. The pharmacokinetics

of Theophylline. Application to adjustment of the clinical dose of

aminophylline. Clin Pharmol Ther 1972; 13:294.

80. Hendeles L, Weinberger m, Johnson G. Monitoring serum

Theophylline levels. Clin Pharmacokinet 1978; 3:294.

81. Wolfe JD, Tashkin DP, Calvarese B, Simmons M. Bronchodilating

effects of Terbutaline and aminophylline alone and in combination in

asthmatic patients. N Engl J Med 1978; 298:363.

82. Billing B, Dahlquist R, Gal M. Seperate and combined use of

Terbutaline and Theophylline in asthmatics. Eur J Respir Dis 1982;

63:399.

83. Svedmyer K, Svedmyer N. Does Theophylline potentiate inhaled β2

agonists? Allergy 1982; 37: 101.

84. Aubier M, De Troyer A, Sampson M, Mecklem PT, Poussos C.

Aminophylline improves diaphragmmatic contractility. N Engl J Med

1981; 305:240.

85. Murciano D, Aubier M, Lecocguic Y, Pariente R. Effects of

theophylline on diaphragmatic strength and fatigue in patients with

chronic obstructive pulmonary disease. N Engl J Med 1984; 311:349.

86. Calhoun WJ, Stevens CA, Lambert SB. Modulation of superoxide

production of alveolar macrophages and peripheral blood

Bibliography


mononuclear cells by beta agonists and Theophylline. J Lab Clin

Med 1991; 117:514.

87. Dent G, Geimbycz Ma, Rabe KF. Theophylline suppresses human

alveolar macrophage respiratory burst through phosphodiesterase

inhibition. Am J Resp Cell Mol Biol 1994; 10: 565.

88. Limatibul S, Shore A, Dosch HM, Gelfand EW. Theophylline

modulation of E- rosette formation: an indicator of T-cell maturation.

Clin Exp Immunol 1978; 33: 503.

89. Bruserud O. The effect of Theophylline on T-lymphocyte activation

in vitro. Clin Immunol Immnuopathol 1984; 32:111.

90. Sullivan PJ, Bekir S, Jaffar Z, Page CP, Costello JF. Anti-

inflammatory effects of low dose oral Theophylline in atopic asthma.

Lancet 1995; 343:1006.

91. Venge P, Dahl R, Karlstrom R, Pedersen B, Peterson CGB.

Eosinophil activity in Asthma in a one year double- blind trial with

theophylline and two doses of inhaled budesonide. J Allergy Clin

Immunol 1992; 89:181.

92. O’Connor J, Towse LJ, barnes PJ. Prolonged effect of tiotropium

bromide on methacholine-induced bronchoconstriction in asthma.

Am J Respir Crit Care Med. 1996; 154:876-80.

93. Jenne JW. Bronchodilators. In: O’Byrne P, Thomson Nc, eds.

Manual of Asthma Management. London: WB Saunders, 1995:291.

94. Ruffin RE, Litzgerald JD, Rebuck As. A comparison of the

bronchodilator activity of Sch 1000 and Salbutamol. J Allergy Clin

Immunol 1977; 59:136.

95. Ullah MI, Newman GB, Saunders KB. Influence of age on response

to ipratropium bromide and Salbutamol in Asthma. Thorax 1981; 36:

Bibliography


523.

96. Van Schayck CP, Folgering H, Harbers H, Maas KL, Van Weel C.

Effec of allergy and age on responses to salbutamol and ipratropium

bromide in moderate asthma and chronic bronchitis. Thorax 1991,

46:355.

97. Howell JBL, Altounyan REC. A double blind trial of Disodium

Cromoglycate in the treatment of asthma in children. Br Med J 1968;

ii: 340.

98. Smith JM, Devey JF. Clinical trial of disodium Cromoglycate in the

treatment of asthma in children. Br Med J 1968; ii: 340.

99. Engstrom I, Kraepelein S. The corticosteroid sparing effect of

disodium cromoglycate (Intal) in children and adolescents with

bronchial asthma. Acta Allergol 1971; 26:90.

100. Brompton Hospital/ Medical Research Council Collaborative Trial.

Long term study of disodium cromoglycate in treatment of severe

extrinisic and intrinsic asthma in adults. Br Med J 1972; iv: 383.

101. Hiller EJ, Milner AD. Bethmethasone 17 valerate aerosol and

disodium cromoglycate in severe blinded asthma. Br J Dis Chest

1975; 69:103.

102. Mitchell I, Paterson IC, Cameron SJ, Grant IWB. Treatment of

childhood asthma with sodium cromoglycate and beclamethsone

dipropionate aerosol singly and in combination. Br Med J 1976; ii:

457.

103. Shapiro GG, Sharpe M, de Rouen TA, Pierson WE, Furukawa CT et

al. Cromolyn versus triamcinalone acetonide for youngsters with

moderate asthma. J Allergy Clin Immunol 1991; 88: 742.

104. Ng SH, Dash CH, Savage SJ. Betamethaosne valerate compared with

Bibliography


sodium cromoglycate in asthmatic children. Postgrad Med J 1977;

14: 315.

105. Francis RS, McEnery G. Disodium cromoglycate compared with

beclamethsone dipropionate in juvenile asthma. Clin Allergy 1984;

14:537.

106. Bar- Yashay E, Gur I, Levy M, VolziniD, Godfrey S et al. Duration

of action of sodium cromoglycate on exercise- induced asthma: a

comparison of 2 formulations. Arch Dis Child 1983; 58: 624.

107. Godfrey S, Belfour- Lynn L, Kőnig P.Tthe place of cromolyn sodium

in the long- term management of childhood asthma based on a 3-5

year follow up. J Paediatr 1975; 87: 465.

108. Brogden RN, Sorkin EM. Nedocromil sodium. An updated review of

its pharmacological properties and therapeutic efficacy in asthma.

Drugs 1993; 79: 64.

109. Kőnig P , Hordvik NL, Krentz C. the preventive and effect and

duration of action of Nedocromil sodium and cromolyn on exercise-

induced asthma( EIA) in adults. J Allergy Clin Immunol 1987; 79:64.

110. North American Tilade Study group. A double blind multicenter

group comparative study of Nedocromil sodium in the management

of asthma. Chest 1990; 97: 1299.

111. Rebuck AS, Kesten S, Boulet LP, Cartier A, Cockcroft D et al. A 3-

month evaluation of the efficacy of nedocromil sodium in asthma: a

randomized , double blind, placebo controlled trial of nedocromil

sodium conducted by a Canadian multicentre study group. J Allergy

Clin Immunol 1990; 85: 612.

112. Bone MF, Kubik MM, Keaney NP, Summers GD, Connolly CK et

al. Nedcromil sodium in adults with Asthma dependent on inhaled

Bibliography


corticosteroids: a double blind, placebo controlled study. Thorax

1989; 44: 654.

113. Boulet LP, Cartier A, Cockcroft DW, Gruber JM, Laberge F et al.

Tolerance to reduction of oral steroid dosage in severely asthmatic

patients recieving nedcromil sodium. Respire Med 1990; 84: 317.

114. Cartier A. anti- allergic drugs. In: O’Byrne P, Thompson NC, eds.

Manual of Asthma Management. London: WB Saunders, 1995:254.

115. Lal S, Dorrow PD, Venho KK, Chatterjee SS. Nedcromil sodium is

more effective than cromolyn sodium for the treatment of chronic

reversible obstructive airways disease. Chest 1993; 104:438.

116. Boldy DA, Ayres JG. Nedcromil sodium and sodium cromoglycate in

patients aged over 50 years with asthma. Respir Med 1993; 87: 517.

117. Rafferty P, Holgate ST. Anti- allergic drugs. In: Barnes PJ, Rodger

IW, Thompson Nc, eds. Asthma: Basic Mechanisms and Clinical

Management. London: Academic Press, 1992: 519. 129.

118. Report to the Medical Research Council by the subcommittee on

Clinical trials in asthma. Controlled trial of effects of cortisone

acetate in chronic asthma. Lancet 1956; i: 798.

119. Fletcher CM. The use of corticosteroids in the treatment of asthma

and related conditions. Postgrad med J 1958; 34: 310.

120. Latinene LA, Latinen A, Haahtel T. A comparative study of the

effects of an Inhaled corticosteroid, budesonide, and of a β2 agonist,

Terbutaline, on airway inflammation in newly diagnosed Asthma. J

Allergy Clin Immunol 1992; 145: 669.

121. Djukanovic R, Wilson JW, Britten YM. Effect of an Inhaled

corticosteroid on airway inflammation and symptoms of Asthma. Am

Rev Respir Dis 1992; 145: 669.

Bibliography


122. Henrikssen JM, Dahl R. Effects of inhaled Budesonide alone in and

in combination with low- dose Terbutaline in children with exercise

induced asthma. Am Rev Respir Dis 1988; 144.

123. Molema J, Van Herwaarden CLA, Folgering HTM. Effect of long

term treatment with inhaled cromoglycate and Budesonide on

bronchial hyperresponsiveness in children with allergic asthma. Eur

Respir J 1989; 2; 308.

124. Haahtela T, Järvinen M, Kava T, Kalstrom L, Gruvstad E et al.

Effects of reducing or discontinuing inhaled Budesonide in patients

with mild asthma. New Engl J Med 1994; 331: 700.

125. Agertoft L, Pederson S. Effects of long-term treatment with an

inhaled corticosteroid on growth and pulmonary functions in

asthmatic children. Respir med 1994; 88: 373.

126. Selroos P, Pietinahlo A, Lofroos A-B, Riska H. Effect of early vs late

intervention with inhaled corticosteroids in asthma. Chest 1995; 108:

1228.

127. Barnes PJ, Pederson S. Efficacy and safety of inhaled corticosteroids

in asthma. Am Rev respire Dis 1993; 148: S1.

128. Lorezon S, Boe J, Eriksson G, Persson G. Use of inhaled

corticosteroids in mild asthma. Thorax 1990;45:733.

129. Jones AH, Langdon CG, Lee PS, Lingham SA, Nankani JP et al.

Pulmicort® Turbohaler® once daily as initial prophylactic therapy for

asthma. Respir Med 1994; 88: 293.

130. HargreaveFE, Dolovich J, Newhouse MT. The assessment and

treatment of asthma: a conference report. J Allergy Clin Immunol

1990; 85: 1098.

131. Toogood JH, High dose inhaled steroid therapy for asthma. J Allergy

Bibliography


Clin Immunol 1989; 83: 528.

132. Laursen LC, Taudorf E, Weeke B. High dose budesonide in treatment

of severe steroid dependent asthma. Eur J Resp Dis 1986; 68: 19.

133. Salmeron S, Guerin J-C, Godard P, Renon D, Henry-Amar M et al.

High doses of inhaled corticosteroids in unstable chronic asthma. Am

Rev respir Dis 1989; 140: 167.

134. Lacronique J, Renon D, Georges D, Henry Amar M, Marsac J. High

dose beclomethasone: oral steroid-sparing effect in severe asthmatic

patients. Eur Respir J 1991; 4: 807.

135. Ernst P, Walter O, Spitzer WD, Suissa S, Cockcroft D et al. Risk of

fatal and near fatal asthma in relation to inhaled corticosteroid use.

JAMA 1992; 268: 3462.

136. Carmichael J, Paterson IC, Diaz P, Crompton GK, Kay AB et al.

Corticosteroid resistance in chronic asthma. Br Med J 1981; 283:

1419.

137. GINA-Global Initiative for Asthma Management and Prevention,

revised edn.2006, Asthma treatment; 47:209.

138. FDA, US Food and Drug Administration, Ban of sale of Ephedra

containing supplements in US, Federal register: 11/02/2004; 69 (28):

6787-6854.

139. Sathyaprabha TN, Murthy H, Murthy BT. Efficacy of Naturopathy

and Yoga in Bronchial Asthma – a self controlled matched scientific

study. Indian journal of Physiology and Pharmacology, 2001;

45(1):80-6.

140. Sri Sivananda swami; The Science of Pranayama. A Divine society

publication, 4th edn: 1998.

141. Patanjali’s Yoga Sutras. Pranayama and Breath control: 2.49- 2.53.

Bibliography


142. B.K. Iyengar: Light on the Yoga Sutras of Patanjali. South Asia

Books; 1st edn., 1993:337.

143. Tandon MK, Adjunct treatment with yoga in chronic severe airway

obstruction, Thorax 1978, Aug; 33(4):514-7.

144. Makwana K, Khirwadkar N, Gupta HC. Effect of short term yoga

practice on ventilatory function tests. Indian Journal of Physiology

and Pharmacology 1988; 32 (3): 202-8.

145. Madanmohan, L Jatiya, K Udupa & AB Bhavanani. Effect of yoga

training on handgrip, respiratory pressures and pulmonary function.

Indian Journal of Physiology Pharmacology,2003; 47(4): 387-392.

146. Nagrathna R, H. R. Nagendra, and R. Seethalakshmi. Yoga chair

breathing for acute episodes of bronchial asthma. Lung India, 1991,

9(4):141-144.

147. Jain SC, Talukdar B. Evaluation of yoga therapy programme for

patients of bronchial asthma. Singapore medical journal, 1993 Aug;

34(4); 306-8.

148. Fluge T, Richter J, Fabel H, Zysno E, Weller E et al. Long-term

effects of breathing exercises and yoga in patients with bronchial

asthma. Pneumologie, 1994, 7; 48(&):484-90.

149. Khanam AA, Sachdeva U, Guleria R, Deepak KK. Study of

pulmonary and autonomic functions of asthma patients after yoga

training. Indian journal of physiology and pharmacology 1996, oct;

40(4); 318-24.

150. Manocha, Ramesh. Sahaja Yoga in asthma. Thorax (9), 2003;

58:825-826.

151. Vedanthan M.D., and N. V. Raghuram. Yoga Breathing Techniques

(YBTs) in exercise induced asthma: A pilot study. International

Bibliography


Journal of Yoga Therapy, 2003, no. 13, 45-49.

152. Sodhi C, Sheena Singh, PK Dandona. A study of the effect of yoga

training on pulmonary functions in patients with bronchial asthma.

Indian J Physiol Pharmacol 2009; 53 (2): 169–174.

153. Vempati R, Bijlani RL, Deepak KK. The efficacy of a comprehensive

lifestyle modification programme based on yoga in the management

of bronchial asthma: a randomized controlled trial. BMC Pulm Med.

2009 Jul 30; 9:37.

154. Tarun Saxena, Manjari Saxena. The effect of various breathing

exercises (pranayama) in patients with bronchial asthma of mild to

moderate severity. Internatonal Journal of Yoga, 2009; 2: 22-25.

155. Chen TL, Mao HC, Lai CH, Li CY, Kuo CH. The effect of yoga

exercise intervention on health related physical fitness in school-age

asthmatic children. Hu li za zhi; The journal of Nursing, 56(2):42-52,

2009 Apr.

156. Singh V, Wisniewski A, Britton J, Tattersfield A. Effect of yoga

breathing exercises (pranayama) on airway reactivity in subjects with

asthma. Lancet 1990 (11); 336(8724):1192.

157. Singh V. Effect of respiratory exercises on asthma. The Pink City

lung exerciser. J Asthma, 1987; 24 (6):355-9.

158. Sabina, A. B., A. L. Williams, H. K. Wall, S. Bansal, G. Chupp, and

D. L. Katz. Yoga intervention for adults with mild-to-moderate

asthma: A pilot study. Annals of Allergy, Asthma and Immunology,

May 2005, 94(5):543-548.

159. Carolyn Kisner, Lynn Allen Colby. Therapeutic Exercise;

Foundations and Techniques; 4th edition 2004.

160. Girodo M, Ekstrand KA, Metivier GJ. Deep diaphragmatic breathing:

Bibliography


rehabilitation exercises for the asthmatic patient. Arch Phys Med

Rehabil.1992;73(8):717-20.

161. M Thomas, R K McKinley, S Mellor, G Watkin, E Holloway et al.

Breathing exercises for asthma: a randomised controlled trial. Thorax

2009; 64:55-61.

162. Buteyko K.P. Oscillogtaphs and Hypertonia. Is "Enhanced"

Breathing Beneficial? Izobretatell I Ratsionalizator. 1962. No.5.

163. Buteyko Institute of Breathing and Health, The Interntional

professional association for the Buteyko Institute method of

Breathing retraining and its practitioners.

164. Simon D Bowler, Amanda Green and Charles A Mitchell. Buteyko

breathing techniques in Asthma: A blinded randomized controlled

trial. MJA 1998; 169: 575-578.

165. Opat AJ, Cohen MM,Bailey MJ, Abramson MJ. A clinical trial of

Buteyko Breathing technique in Asthma as taught by video. Journal

of Asthma 2000, 37(7), 667-564.

166. Institutional Ethics Committee, Kasturba Medical College, Manipal

University, Mangalore, December 2005.

167. American Thoracic Society/ European Respiratory Society Task

force: Standardisation of Lung Function testing, Number 2:

Standardization of Spirometry, Eur Respir J 2005: 26:948-968.

168. Manual of Pulmonary Function Testing, Gregg L Ruppel, 9th edn,

2009, 61-63, Mosby.

169. Mithoefer,J.C. (1964). Breath Holding. In Handbook of Physiology,

Section 3: Respiration, Vol II, 1011-1025, American Physiological

Society.

170. American thoracic society, Guidelines for the Six-Minute Walk Test,

Bibliography


Official statement of the American thoracic society was approved by

ATS, the Board of directors, March 2002.

171. Troosters T, Gosselink R, Decramer M. Six minute walking distance

in healthy elderly subjects. Eur Respir J, 1999; 14:270–274.

172. Darbee, Joan C, Ohtake, Patricia J, Outcome measures in

Cardiopulmonary physical therapy: Medical Research Council

(MRC) Dyspnoea scale. Cardiopulmonary Physiotherapy Journal, 24

(6) 2009.

173. Terry S, LeGrand and David C Shelledy, University of Texas Health

Science Centre, 2002 Open Forum Abstracts, Respiratory Care, The

Science Journal of American Association For Respiratory Care.

174. Nagarathna R, Nagendra H.R., R Seethalaxmi. Daily PEFR studies in

bronchial Asthmatics during yoga therapy. The Indian Practitioner,

1991 (7): 491-493.

175. Rachna Sirohi, Effect of Nadi Shodhan pranayama on Forced Vital

Capacity, Dept. of yoga; dsvv publications.

176. M Mazhar Hussain, Ahmad Kamal Ansari. Ventilatory lung functions

and absolute eosinophil count in adult asthamatics. Pak Armed forces

Med J, Dec 1998; 48(2): 117-22.

177. M Mazhar Hussain, Ahmed Kamal Ansari. Ventilatory functions and

total serum IgE in bronchial asthma. Pak Med Forces J, Dec1996; 46

(2): 3-10.

178. Udupa KN, Singh RH. The scientific basis of yoga. JAMA 1972,

220:1365.

179. Beeh KM, Derom E, Kanniess F et al. Indicaterol, a novel inhaled

beta – 2 agonist provides a sustained 24-h bronchodilation in Asthma.

Eur Respir J, 2007 May; 29(5):871-8.

Bibliography


180. National Heart Lung and Blood Institute – National Institutes of

Health. Guidelines for the diagnosis & management of Asthma.

2007, Pg.63-79.

181. Chowgule RV, Shetye VM, Parmar JR, Bhosale AM, Khandagale

MR, Phalnitkar SV, et al. Prevalence of respiratory symptoms,

bronchial hyperreactivity, and asthma in a megacity: results of the

European Community Respiratory Health Survey in Mumbai

(Bombay). Am J Respir Crit Care Med 1998; 158: 547- 54.

182. Aggarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta

D, Jindal SK, Katiyar SK, Kumar R, Shah B, Vijayan VK; Asthma

Epidemiology Study Group. Prevalence and risk factors for bronchial

asthma in Indian adults: a multicentre study. Indian J Chest Dis

Allied Sci. 2006 Jan-Mar; 48(1):13-22.

183. Murthy KJR, Sastry JG. Economic burden of asthma. NCMH

Background Papers—Burden of disease in India, 2005.

bibliogrbibliography aphyaphy -...

Documents